Jump to main content
Jump to site search

Issue 3, 2010
Previous Article Next Article

Fabrication and functional characterization of goldnanoconjugates for potential application in ovarian cancer

Author affiliations

Abstract

In this paper we report the surface modification and functional characterization of a gold nanoparticle-based drug delivery system for potential therapeutic application in ovarian cancer. It is currently recognized that nanotechnology may play a pivotal role in drug delivery by increasing efficacy and reducing toxicity of anticancer drugs. Here, we report the fabrication of a gold nanoparticle (AuNP) based drug delivery system consisting of folic acid (FA), mercapto-polyethylene glycol (PEG-SH) with a molecular weight of 2000 (designated as PSH2-2 K or PSH) and cis-platin (CP) [Au-PSH-CP-FA] for potential therapeutic application in ovarian cancer. Fabrication is done in a three step incubation process at room temperature (RT). The gold nanoconjugates are characterized with several physico-chemical techniques such as UV-Vis (UV-visible spectroscopy), TEM (transmission electron microscopy), ICP (inductively coupled plasma) and radioactivity measurement with a scintillation counter. Attachment and release profiles of FA from the gold nanoconjugates are performed using 3H-labelled FA (3H-FA). The expressions of folate receptor (FR) for ovarian cancer cell lines (OV-167, OVCAR-5), human umbilical vein endothelial cells (HUVEC) and ovarian surface epithelial (OSE) cells are determined by FACS analysis. Quantitation of platinum content in the nanoconjugates and its release profile is determined by platinum (Pt) analysis using ICP-MS. Biological functional characterization using in vitro proliferation assay demonstrates that Au-PSH-CP-FA not only retains the cytotoxic effect of CP, but it protects the normal cells from the cytotoxic insult, while enhancing the cytotoxic effect on the tumor cells. In future, this strategy may be utilized as a strategy for the treatment of ovarian cancers and may overcome the core side effect issues in anticancer therapy.

Graphical abstract: Fabrication and functional characterization of goldnanoconjugates for potential application in ovarian cancer

Back to tab navigation
Please wait while Download options loads

Publication details

The article was received on 03 Jul 2009, accepted on 15 Oct 2009 and first published on 17 Nov 2009


Article type: Paper
DOI: 10.1039/B913224D
Citation: J. Mater. Chem., 2010,20, 547-554
  •   Request permissions

    Fabrication and functional characterization of goldnanoconjugates for potential application in ovarian cancer

    C. R. Patra, R. Bhattacharya and P. Mukherjee, J. Mater. Chem., 2010, 20, 547
    DOI: 10.1039/B913224D

Search articles by author